EUVIMEDEUVIMED entdecken
Crossref

Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States

Ashley N Dowd iD, C Austin Zamarripa iD, Dennis J Sholler, Edward J Cone, Timothy P Murphy, Mahmoud ElSohly, Kareem ElSohly, Waseem Gul iD, Iram Shahzadi, Lawrance D Mullen iD, Ruth E Winecker, Ronald R Flegel und 2 weitere

Cannabis & Cannabinoid Research · 01.12.2025 · 10 (6) · 719-725

DOI: 10.1089/can.2024.0039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, online erschienen am 19.07.2024. Verfasst von Ashley N Dowd und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Cosmetics, Cannabis, Cannabinoids, Product Labeling. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the label accuracy and content of various hemp-derived cannabidiol (CBD) products (cannabinoid products with ≤0.3% Δ 9 -tetrahydrocannabinol [THC]), as well as evaluate advertised claims on product labels.

Methods

Hemp haircare, cosmetics, and food/drink products that were advertised to contain CBD were purchased from retail stores in the Baltimore, Maryland area (purchased in July 2020) and online (purchased in August 2020). Cannabinoid concentrations were measured using gas chromatography–mass spectrometry. Percent deviations between labeled and actual CBD concentrations were determined. Label information such as references to the Food and Drug Administration (FDA), external testing claims, and other claims (i.e., cosmetic or beauty, therapeutic, health halo effect, or “other”) were quantified.

Results

Ninety-seven products were purchased (35 in-store, 62 online). Of the 71 products with a specific total CBD amount on the label, 35 (49%) were underlabeled (>10% more CBD than advertised), 27 (38%) were overlabeled (>10% less CBD than advertised), and 9 (12.7%) were accurately labeled (within ±10% of labeled CBD). The median (range) percentage deviations were −53% (−100%–76%) for haircare products, +18% (−100%−1076%) for cosmetics, and −1% (−100%−4468%) for food/drinks. CBD label accuracy did not differ significantly between products with external testing claims versus those without ( t 40 = 0.23, p = 0.82). Overall, 24% of the 97 (total) products made a cosmetic or beauty claim (e.g., “skin looks more youthful”), 40% made a therapeutic claim (e.g., “pain relief”), and 86% made a health halo effect claim (e.g., “paraben-free,” “dye-free,” etc.). Most products (63%) did not include a disclaimer that claims had not been evaluated by the FDA.

Conclusions

Most of the products included in this sample were inaccurately labeled for CBD content, including those claiming to have been tested by third party laboratories. A notable finding was that 10 products did not contain any CBD. Many products made therapeutic claims or used marketing tactics to seemingly convey they were safe/healthy, but only about one-third included disclaimers that these statements had not been evaluated by the FDA. These findings highlight the need for proper regulatory oversight of cannabinoid-containing products to ensure quality assurance and deter misleading or unfounded health claims in product marketing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CosmeticsCannabisCannabinoidsProduct LabelingCannabidiolUnited StatesHumansGas Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

CBDTHCcannabidiolhemptetrahydrocannabinol

Substanzen

CosmeticsCannabinoidsCannabidiol

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • ElSohly Laboratories Inc, Oxford, Mississippi, USA.
  • RTI International, Research Triangle, North Carolina, USA.
  • Division of Workplace Programs, Substance Abuse and Mental Health Services Administration, Rockville, Maryland, USA.

ORCID-Profile: Ashley N Dowd, C Austin Zamarripa, Waseem Gul, Lawrance D Mullen

Zitieren

APA

Dowd, A. N., Zamarripa, C. A., Sholler, D. J., Cone, E. J., Murphy, T. P., ElSohly, M., ElSohly, K., Gul, W., Shahzadi, I., Mullen, L. D., Winecker, R. E., Flegel, R. R., Vandrey, R., & Spindle, T. R. (2025). Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States. Cannabis & Cannabinoid Research, 10(6), 719-725. https://doi.org/10.1089/can.2024.0039

Vancouver

Dowd AN, Zamarripa CA, Sholler DJ, Cone EJ, Murphy TP, ElSohly M, et al. Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States. Cannabis & Cannabinoid Research. 2025;10(6):719-725. doi:10.1089/can.2024.0039

BibTeX
@article{Dowd2025,
  author = {Dowd, Ashley N and Zamarripa, C Austin and Sholler, Dennis J and Cone, Edward J and Murphy, Timothy P and ElSohly, Mahmoud and ElSohly, Kareem and Gul, Waseem and Shahzadi, Iram and Mullen, Lawrance D and Winecker, Ruth E and Flegel, Ronald R and Vandrey, Ryan and Spindle, Tory R},
  title = {Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States},
  journal = {Cannabis & Cannabinoid Research},
  year = {2025},
  volume = {10},
  number = {6},
  pages = {719--725},
  doi = {10.1089/can.2024.0039}
}
Kostenlos starten →